Download
fimmu-12-720716.pdf 798,74KB
WeightNameValue
1000 Titel
  • Immediate Pre-Partum SARS-CoV-2 Status and Immune Profiling of Breastmilk: A Case-Control Study
1000 Autor/in
  1. Sánchez García, Laura |
  2. Gómez-Torres, Natalia |
  3. Cabañas, Fernando |
  4. González-Sánchez, Raquel |
  5. López-Azorín, Manuela |
  6. Moral-Pumarega, M. Teresa |
  7. Escuder-Vieco, Diana |
  8. Cabañes-Alonso, Esther |
  9. Castro, Irma |
  10. Alba, Claudio |
  11. Rodríguez Gómez, Juan Miguel |
  12. Pellicer, Adelina |
1000 Verlag
  • Frontiers Media S.A.
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-26
1000 Erschienen in
1000 Quellenangabe
  • 12:720716
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-28
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fimmu.2021.720716 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350512/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:sec><jats:title>Objetive</jats:title><jats:p>To address the prevalence of SARS-CoV-2 and the evolutionary profile of immune compounds in breastmilk of positive mothers according to time and disease state.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Forty-five women with term pregnancies with confirmed non-severe SARS-CoV-2 infection (case group), and 96 SARS-CoV-2 negative women in identical conditions (control group) were approached, using consecutive sample. Weekly (1st to 5th week postpartum) reverse transcription polymerase chain reaction (RT-PCR) in nasopharyngeal swabs (cases) and breastmilk (cases and controls) were obtained. Concentration of cytokines, chemokines, and growth factors in breastmilk (cases and controls) were determined at 1st and 5th week post-partum.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Thirty-seven (study group) and 45 (control group) women were enrolled. Symptomatic infection occurred in 56.8% of women in the study group (48% fever, 48% anosmia, 43% cough). SARS-CoV-2 RNA was not found in breastmilk samples. Concentrations of cytokines (IFN-γ, IL-1ra, IL-4, IL-6, IL-9, IL-13, and TNF-α) chemokines (eotaxin, IP-10, MIP-1α, and RANTES) and growth factors (FGF, GM-CSF, IL7, and PDGF-BB) were higher in breastmilk of the study compared with the control group at 1st week postpartum. Immune compounds concentrations decreased on time, particularly in the control group milk samples. Time of nasopharyngeal swab to become negative influenced the immune compound concentration pattern. Severity of disease (symptomatic or asymptomatic infection) did not affect the immunological profile in breast milk.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>This study confirms no viral RNA and a distinct immunological profile in breastmilk according to mother’s SARS-CoV-2 status. Additional studies should address whether these findings indicate efficient reaction against SARS-CoV-2 infection, which might be suitable to protect the recipient child.</jats:p></jats:sec>
1000 Sacherschließung
lokal Infant, Newborn [MeSH]
gnd 1206347392 COVID-19
lokal Female [MeSH]
lokal Immunology
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal RNA, Viral [MeSH]
lokal COVID-19
lokal vertical infectious disease transmission
lokal immune system
lokal Intercellular Signaling Peptides and Proteins/analysis [MeSH]
lokal Milk, Human/immunology [MeSH]
lokal immunologic factors
lokal COVID-19 [MeSH]
lokal Milk, Human/chemistry [MeSH]
lokal Case-Control Studies [MeSH]
lokal Mothers [MeSH]
lokal Chemokines/analysis [MeSH]
lokal Breast Feeding [MeSH]
lokal Cytokines/analysis [MeSH]
lokal breastfeeding
lokal Pregnancy [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U8OhbmNoZXogR2FyY8OtYSwgTGF1cmE=|https://frl.publisso.de/adhoc/uri/R8OzbWV6LVRvcnJlcywgTmF0YWxpYQ==|https://frl.publisso.de/adhoc/uri/Q2FiYcOxYXMsIEZlcm5hbmRv|https://frl.publisso.de/adhoc/uri/R29uesOhbGV6LVPDoW5jaGV6LCBSYXF1ZWw=|https://frl.publisso.de/adhoc/uri/TMOzcGV6LUF6b3LDrW4sIE1hbnVlbGE=|https://frl.publisso.de/adhoc/uri/TW9yYWwtUHVtYXJlZ2EsIE0uIFRlcmVzYQ==|https://frl.publisso.de/adhoc/uri/RXNjdWRlci1WaWVjbywgRGlhbmE=|https://frl.publisso.de/adhoc/uri/Q2FiYcOxZXMtQWxvbnNvLCBFc3RoZXI=|https://frl.publisso.de/adhoc/uri/Q2FzdHJvLCBJcm1h|https://frl.publisso.de/adhoc/uri/QWxiYSwgQ2xhdWRpbw==|https://frl.publisso.de/adhoc/uri/Um9kcsOtZ3VleiBHw7NtZXosIEp1YW4gTWlndWVs|https://frl.publisso.de/adhoc/uri/UGVsbGljZXIsIEFkZWxpbmE=
1000 Hinweis
  • DeepGreen-ID: cfbe6d12faba41eea583a4338d3f2c53 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Instituto de Salud Carlos III |
  2. Ministerio de Ciencia, Innovación y Universidades |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Instituto de Salud Carlos III |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Ministerio de Ciencia, Innovación y Universidades |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6479786.rdf
1000 Erstellt am 2024-05-22T00:01:57.175+0200
1000 Erstellt von 322
1000 beschreibt frl:6479786
1000 Zuletzt bearbeitet 2024-05-22T14:37:34.906+0200
1000 Objekt bearb. Wed May 22 14:37:34 CEST 2024
1000 Vgl. frl:6479786
1000 Oai Id
  1. oai:frl.publisso.de:frl:6479786 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source